Education
About Us
Working with TipRanks
Follow Us
Entheon Biomedical (ENTBF)
OTHER OTC:ENTBF
Total Valuation
Entheon Biomedical has a market cap or net worth of $1.11M. The enterprise value is $14.46M.
Market Cap$1.11M
Enterprise Value$14.46M
Share Statistics
Entheon Biomedical has 13,858,926 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,858,926
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Entheon Biomedical’s return on equity (ROE) is -2.19 and return on invested capital (ROIC) is -198.22%.
Return on Equity (ROE)-2.19
Return on Assets (ROA)-1.72
Return on Invested Capital (ROIC)-198.22%
Return on Capital Employed (ROCE)-1.98
Revenue Per Employee0.00
Profits Per Employee-317.92K
Employee Count1
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Entheon Biomedical is -3.41. Entheon Biomedical’s PEG ratio is -19.86.
PE Ratio-3.41
PS Ratio0.00
PB Ratio8.70
Price to Fair Value7.45
Price to FCF-24.80
Price to Operating Cash Flow-70.89
PEG Ratio-19.86
Income Statement
In the last 12 months, Entheon Biomedical had revenue of 0.00 and earned -318.00K in profits. Earnings per share was -0.04.
Revenue0.00
Gross Profit0.00
Operating Income-333.00K
Pretax Income-318.00K
Net Income-318.00K
EBITDA-318.00K
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -372.26K and capital expenditures 4.00, giving a free cash flow of -372.25K billion.
Operating Cash Flow-372.26K
Free Cash Flow-372.25K
Free Cash Flow per Share-0.03
Dividends & Yields
Entheon Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.78
52-Week Price Change40.00%
50-Day Moving Average0.08
200-Day Moving Average0.11
Relative Strength Index (RSI)41.40
Average Volume (3m)179.00
Important Dates
Entheon Biomedical upcoming earnings date is Jul 29, 2025, TBA Not Confirmed.
Last Earnings DateApr 1, 2025
Next Earnings DateJul 29, 2025
Ex-Dividend Date―
Financial Position
Entheon Biomedical as a current ratio of 10.41, with Debt / Equity ratio of 0.00%
Current Ratio10.41
Quick Ratio10.41
Debt to Market Cap0.00
Net Debt to EBITDA0.43
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Entheon Biomedical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Entheon Biomedical EV to EBITDA ratio is -2.98, with an EV/FCF ratio of -2.66.
EV to Sales0.00
EV to EBITDA-2.98
EV to Free Cash Flow-2.66
EV to Operating Cash Flow-2.66
Balance Sheet
Entheon Biomedical has $525.16K in cash and marketable securities with C$0.00 in debt, giving a net cash position of -$525.16K billion.
Cash & Marketable Securities$525.16K
Total DebtC$0.00
Net Cash-$525.16K
Net Cash Per Share-$0.04
Tangible Book Value Per Share$0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Entheon Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―